2010
High perioperative level of oxidative stress as a prognostic tool for identifying patients with a high risk of recurrence of head and neck squamous cell carcinoma
SALZMAN, Richard; Lukáš PÁCAL; Kateřina KAŇKOVÁ; Josef TOMANDL; Zuzana HORÁKOVÁ et al.Základní údaje
Originální název
High perioperative level of oxidative stress as a prognostic tool for identifying patients with a high risk of recurrence of head and neck squamous cell carcinoma
Autoři
SALZMAN, Richard; Lukáš PÁCAL; Kateřina KAŇKOVÁ; Josef TOMANDL ORCID; Zuzana HORÁKOVÁ; Eva TOTHOVA a Rom KOSTŘICA
Vydání
International Journal of Clinical Oncology, 2010, 1341-9625
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30200 3.2 Clinical medicine
Stát vydavatele
Japonsko
Utajení
není předmětem státního či obchodního tajemství
Impakt faktor
Impact factor: 1.437
Označené pro přenos do RIV
Ano
Kód RIV
RIV/00216224:14110/10:00040779
Organizační jednotka
Lékařská fakulta
UT WoS
Klíčová slova anglicky
Glutathione peroxidase; Head and neck cancer; Malondialdehyde; oxidative stress; prognostic marker
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 6. 6. 2012 08:55, doc. RNDr. Josef Tomandl, Ph.D.
Anotace
V originále
BACKGROUND: The aim of the study was to investigate the relationships among (a) glutathione peroxidase (GPx) and malondialdehyde (MDA); (b) oncological characteristics (i.e., TNM classification, tumor grade), and; (c) prognosis of head and neck squamous cell carcinoma. METHODS: In a prospective cohort study, we followed 88 patients for 67.4 months (median 40.3) after surgery for head and neck squamous cell carcinoma. Activity of GPx was determined by ELISA and plasma MDA concentration by liquid chromatography. RESULTS: Lower GPx activity was observed in the T3/4 patients than in the T1/2 group. Tumor grade was significantly correlated with both GPx (P = 0.001) and MDA (P = 0.05, both Spearman). The perioperative level of MDA was higher in patients who later recurred during the follow-up period (n = 15) than in the complete remission group (P = 0.01, Mann-Whitney). Median disease-free interval and overall survival in the group with MDA > median were 29.5 and 32.0 months, respectively, and 38.4 and 40.3 months in the patient group with MDA
Návaznosti
| NR9200, projekt VaV |
|